戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ing MS relative to weight (handgrip strength/body mass).
2 AN, ADAMTSL3, and IRS1 for appendicular lean body mass.
3 here has been a genetic change towards lower body mass.
4 muscle mass and is therefore associated with body mass.
5 h could be estimated from knowing a species' body mass.
6  in subfossil and modern species scaled with body mass.
7 ions were significantly altered by increased body mass (90 of 130) and T2DM (56 of 130).
8 ts in FFM were commensurate with the reduced body mass; although men in the CR group lost more FFM th
9                                       Per kg body mass, an infant will receive a nearly four times gr
10 proach, we examined the relationship between body mass and demography in a small mammal population th
11 wide association studies for whole body lean body mass and find five novel genetic loci to be signifi
12  that despite a positive association between body mass and fitness, there has been a genetic change t
13 VCAN, ADAMTSL3, IRS1, and FTO for total lean body mass and for three single-nucleotide polymorphisms
14 ividuals from 33 cohorts for whole body lean body mass and in 45,090 (42,360 of European ancestry) su
15 was found to have beneficial effects on lean body mass and leg power in elderly men.
16 capillary wedge pressure was correlated with body mass and plasma volume in obese HFpEF (r=0.22 and 0
17 gation of the underlying coupled dynamics of body mass and population growth has been lacking.
18  We controlled for phylogenetic relatedness, body mass and the size of the plots over which densities
19 ts may cause larger seasonal fluctuations in body mass and vital rates.
20 reased serum levels of WISP2, increased lean body mass and whole body energy expenditure, hyperplasti
21 n occurs; how EWL and die-off risk vary with body mass; and how die-off risk is affected by climate w
22             Genes near loci regulating total body mass are enriched for expression in the CNS, wherea
23 (meldonium, n = 8) for 10 days [1.6 g kg(-1) body mass (BM) day(-1) days 1-2, 0.8 g kg(-1) BM day(-1)
24 s such that extinction risk changes around a body mass breakpoint of 0.035 kg, indicating that the li
25 rmonal bionic pancreas initialised only with body mass can safely reduce mean glycaemia and hypoglyca
26 s, clearance of Htt aggregates and preserves body mass compared with HD mice homozygous for CK2alpha'
27 orphology and function depend on the type of body mass composition.
28                                         Lean body mass, consisting mostly of skeletal muscle, is impo
29                                      October body mass (CV = 2.5%) increased over the study due to hi
30                                              Body mass decreased by 17.6% and then dramatically incre
31 isms were significantly associated with lean body mass either genome wide (p < 5 x 10(-8)) or suggest
32                            With an estimated body mass exceeding 1,300 kg, B. markmitchelli was much
33                          Late winter (April) body mass explained 88% of the between-year variation in
34 nd skeletal muscle ammonia, increase in lean body mass, improved grip strength, higher skeletal muscl
35  an understanding of the importance of size (body mass) in structuring these communities.
36 s), history of near-fatal asthma (+1 point), body mass index >/=25kg/m(2) (+1 point), obstructive sle
37 dered a problem of Western nations, obesity (body mass index >/=30 kg/m(2)) has rapidly increased sin
38 line (age 45-64 years; risk factors included body mass index >/=30, current smoking, hypertension, di
39                   Subjects with obese HFpEF (body mass index >/=35 kg/m(2); n=99), nonobese HFpEF (bo
40 ome and/or revascularization, with >/=1 LRF (body mass index >27 kg/m(2), self-reported physical inac
41  CHA2DS2-VASc score of >/=2, sleep apnea, or body mass index >30 kg/m(2).
42  index >/=35 kg/m(2); n=99), nonobese HFpEF (body mass index <30 kg/m(2); n=96), and nonobese control
43 irst-degree family history of breast cancer, body mass index (>25 vs 18.5-25), history of benign brea
44 sting for phenotypic resistance profile, low body mass index (<18.5 kg/m2), human immunodeficiency vi
45  -4.95 to -0.75]; 19 trials [n = 9325]), and body mass index (-0.41 [95% CI, -0.62 to -0.19]; 20 tria
46 ocardial infarction (28% versus 22%), higher body mass index (31 versus 29 kg/m(2)), worse Minnesota
47 ] vs 10 years [range, 2-26 years]), and mean body mass index (31.4 kg/m(2) [range, 24.7-48.1 kg/m(2)]
48 ar ejection fraction (B=-0.81, SE=0.20), and body mass index (B=-3.55, SE=0.46; P<0.001).
49 ncing age (beta, -0.14; P < .001), increased body mass index (beta, -0.15; P = .001), spherical equiv
50 cts on height (>2.4 cm), weight (>5 kg), and body mass index (BMI) (>3.5 kg/m(2)).
51 ger), which were predictive of having a high body mass index (BMI) and being obese.
52 tained by a modified diet history method) on body mass index (BMI) and body fat percentage.Results:AM
53 ing pregnancy was associated with children's body mass index (BMI) and detailed measures of body comp
54 o determine if associations between maternal body mass index (BMI) and offspring systemic cardio-meta
55  Perfluoroalkyl substances (PFAS) may affect body mass index (BMI) and other components of cardiometa
56 udy the associations between early pregnancy body mass index (BMI) and rates of cerebral palsy by ges
57 gate the association between early pregnancy body mass index (BMI) and the risk of childhood epilepsy
58 e risk score for obesity (GPRS-obesity) with body mass index (BMI) and waist circumference (WC) was m
59             Anthropometric indices including body mass index (BMI) and waist circumference (WC) were
60 d Nutrition Examination Survey, we regressed body mass index (BMI) and waist-to-height ratios on urin
61 ure-time physical activity (LTPA) and higher body mass index (BMI) are independently associated with
62                   Results were similar using body mass index (BMI) as an anthropometric indicator of
63 diatric patients were identified as having a body mass index (BMI) at or above the 85th percentile an
64 l sclerosis (ALS) may be associated with low body mass index (BMI) at the time of diagnosis.
65                       Further adjustment for body mass index (BMI) attenuated these associations but
66 r TCF7L2, CDKN2AB and CDKAL1) overestimated (body mass index (BMI) decreasing) and one (near MTNR1B)
67    Secular trends in blood pressure (BP) and body mass index (BMI) during childhood and adolescence a
68 cations occur more frequently and at a lower body mass index (BMI) in Asians than in European populat
69 ght gain (GWG) during pregnancy and maternal body mass index (BMI) in early pregnancy are associated
70                                         High body mass index (BMI) is an important contributor to the
71                                              Body mass index (BMI) is used to diagnose obesity in ado
72 n (SD) age of 15.1 (1.7) years and mean (SD) body mass index (BMI) of 30.2 (3.5) kg/m(2) in obese and
73 erform kidney transplant in individuals with body mass index (BMI) of 40 kg/m or greater.
74  Calcium retention increases with increasing body mass index (BMI) on recommended calcium intakes.
75          Prior to the onset of AN, premorbid body mass index (BMI) spans the entire range from underw
76                               The total mean body mass index (BMI) was 24.7 +/- 4.2 kg/m(2).
77  Child Feeding Questionnaire, and children's body mass index (BMI) was measured.
78                                   Changes in body mass index (BMI) were based on SSB consumption, BMI
79  x SNP interaction association analyses with body mass index (BMI) were evaluated in the 100 subjects
80                              Paternal age or body mass index (BMI) were not associated with NAFLD in
81 sures might be more strongly associated than body mass index (BMI) with childhood asthma.
82 ity, we sought to examine the association of body mass index (BMI) with FPM/SPM emergence in a repres
83 dy was aimed to determine the association of body mass index (BMI) with mortality and functional outc
84 posure to p,p'-DDE and adiposity assessed by body mass index (BMI) z-score.
85 re for waist-to-hip ratio (WHR) adjusted for body mass index (BMI), a measure of abdominal adiposity,
86 , and at 1, 3, and 6 months included weight, body mass index (BMI), body composition, muscle strength
87 ations were identified between tiredness and body mass index (BMI), C-reactive protein, high-density
88 site, patient age, reported smoking history, body mass index (BMI), diabetes, HIV, and all other resi
89 studies (GWAS) have identified >250 loci for body mass index (BMI), implicating pathways related to n
90    Independent predictors of MAC-PP were low body mass index (BMI), radiographic nodular-bronchiectat
91 tic relation with 10 obesity-related traits [body mass index (BMI), waist circumference (WC), high-de
92 ponses used in the statistical analyses were body mass index (BMI), waist circumference (WC), serum a
93 ntral obesity with hypertension, and between body mass index (BMI), waist circumference (WC), waist-t
94                                   Stress-T1, body mass index (BMI)-T1 and HRQoL-T0 significantly and
95 l differences in food craving and changes in body mass index (BMI).
96 residual confounding by healthy lifestyle or body mass index (BMI).
97 ypothesis" linking food insecurity to a high body mass index (BMI).
98 terol, higher total homocysteine, and higher body mass index (BMI)] and greater odds of large-vessel
99                                              Body mass index (BMI, calculated as weight in kilograms
100                                  Achieving a body mass index (BMI, calculated as weight in kilograms
101  use epigenome-wide association to show that body mass index (BMI; a key measure of adiposity) is ass
102 .0 +/- 0.03 g/cm(2) for groups with baseline body mass index (BMI; in kg/m(2)) >/=30 and <30, respect
103 h 350 and 33 were associated with changes in body mass index (BMI; in kg/m(2)) and Matsuda index valu
104 es were tested by analysis of variance.Three body mass index (BMI; in kg/m(2)) trajectory patterns we
105                        Handgrip strength and body mass index (BMI; in kg/m(2)) were measured at basel
106 utcomes glycated hemoglobin (HbA1c), weight, body mass index (BMI; in kg/m(2)), and LDL cholesterol.
107 ts on outcomes related to weight management [body mass index (BMI; in kg/m(2)), body weight, percenta
108 ts of GS and adiposity indicators, including body mass index (BMI; in kg/m(2)).
109            Participants had above-the-median body mass index (BMI; in kg/m(2)).We enrolled 274 health
110   Participants were thin at 1 wk postpartum [body mass index (BMI; in kg/m(2)): 22.9 +/- 2.9].
111  and 155 women; mean +/- SD age: 25 +/- 6 y; body mass index (BMI; in kg/m(2)): 23 +/- 2].
112          For older groups, being overweight [body mass index (BMI; in kg/m(2)): 25 to <30] is reporte
113 e whether associations of breast cancer with body mass index (BMI; weight (kg)/height (m)2) at age 18
114 ween neighborhood food environment and adult body mass index (BMI; weight (kg)/height (m)2) derived u
115  analyses "adjusting" for height, weight, or body mass index (BMI; weight (kg)/height (m)2) measured
116 ons between neighborhood characteristics and body mass index (BMI; weight (kg)/height (m)2) were asse
117 ned the association of maternal prepregnancy body mass index (BMI; weight (kg)/height (m)2), gestatio
118 strategy, patients remained at their initial body mass index (calculated as weight in kilograms divid
119              Donor obesity, defined as donor body mass index (D-BMI) of 30 kg/m or greater, has been
120 duration; glycated hemoglobin 7.0% +/- 0.8%; body mass index (in kg/m(2)) 28.2 +/- 2.9] completed 57
121 ed trial, 220 participants aged 18-60 y with body mass index (in kg/m(2)) from 27.6 to 40.4 were incl
122 cipants.Ten healthy lean participants with a body mass index (in kg/m(2)) of 22.4 +/- 0.8 were subjec
123 imed to investigate the associations between body mass index (in kg/m(2)), fat mass, fat-free mass, a
124 en [49 men and 32 women; age range: 40-65 y; body mass index (in kg/m(2)): <35.0].
125 controlled crossover trial, 17 participants [body mass index (in kg/m(2)): 23.7 +/- 4.6] underwent 3
126 ipants [n = 20-22; women: 50%; age: 50-80 y; body mass index (in kg/m(2)): 25-30)] received food chal
127 ty-four healthy, older men [age: 62 +/- 1 y; body mass index (in kg/m(2)): 25.9 +/- 0.4 (mean +/- SEM
128 omized trial, 29 men aged >70 y [mean +/- SD body mass index (in kg/m(2)): 28.3 +/- 4.2] were provide
129 men and women [mean +/- SEM age: 35 +/- 2 y; body mass index (in kg/m(2)): 31.5 +/- 0.5] consumed an
130 hypertension (735 [69.1%]; P < .001), higher body mass index (median [IQR], 32.4 [28.1-38.3]; P < .00
131          However, sets of alleles increasing body mass index (P=2.2x10(-5)) and the risk of type 2 di
132 sk ratio 83.3/20.3, 4.1, p < 0.0001), higher body mass index (prevalence risk ratio 40.5/4.8, 8.4, p
133 ia, type 2 diabetes mellitus, and changes in body mass index (proportion accounted for, 14.5%; 95% CI
134 lcohol intake (RR, 1.33; 95% CI, 1.17-1.52), body mass index (RR, 1.40; 95% CI, 1.22-1.61), and high
135  blood pressure (Spearman r=0.28, P<0.0001), body mass index (Spearman r=0.28, P<0.0001), weaker grip
136  </=2, WHO/ECOG score </=1, age </=65 years, body mass index 19-29 kg/m).
137 5 NAFL, and 37 NASH; mean age 51.8 years and body mass index 31.9 kg/m(2) ), 66% were women.
138 sults In this obese patient population (mean body mass index = 40.3 kg/m(2); 95% confidence interval
139 aged >50 y who had knee osteoarthritis and a body mass index [BMI (in kg/m(2))] >/=30.
140 level >/= 20 for women or >/= 31 for men and body mass index [BMI] > 25 kg/m(2) ), healthy non-NAFLD
141 imary outcome measure was child weight loss (body mass index [BMI] and BMI z score) at 6, 12, and 18
142 genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [
143 ss index [WHRadjBMI]) and general adiposity (body mass index [BMI]) with cardiometabolic disease.
144 stigated the associations between body size (body mass index [BMI], height, waist circumference, and
145                 Weight or excess weight (eg, body mass index [BMI]; BMI z score, measuring the number
146 CI 1.06-1.64 per standard deviation score in body mass index [SDS-BMI]).
147 l adiposity (waist-to-hip ratio adjusted for body mass index [WHRadjBMI]) and general adiposity (body
148 nverse probability weights based on baseline body mass index and a propensity score estimated from ba
149     Blood pressure, non-fasting blood sugar, body mass index and abdominal girth were measured.
150 howed sex differences for the association of body mass index and AF (hazard ratio per standard deviat
151 ta in an analysis of the association between body mass index and all-cause mortality among people wit
152          New 2016 CDC models only adjust for body mass index and diabetes.
153 ody mass index, where the variables baseline body mass index and glycosylated hemoglobin have missing
154                                              Body mass index and HDL cholesterol were negatively corr
155                      The association between body mass index and mortality was investigated using Cox
156 one genome-wide significant interaction with body mass index and several suggestive interactions with
157                                      We used body mass index and waist circumference to define genera
158       There was no significant difference in body mass index between both treatment regimens.
159    Participants were stratified based on the body mass index categories and metabolic condition.
160 ral nutrition, the survival disadvantage for body mass index categories less than 25.0 kg/m was minim
161 al or unobservable when compared with higher body mass index categories.
162                     Exposure of interest was body mass index categorized into 6 groups according to t
163 eral nutrition, the risk of mortality in the body mass index category 25.0-29.9 kg/m was not statisti
164                                    The Asian body mass index cutoff of 25 kg/m(2) was used to define
165                               Setting strict body mass index cutoffs for transplant candidacy remains
166                               Compliance and body mass index did not modify the treatment effect.
167                                              Body mass index explained the largest proportion of AF r
168  = 0.6 SD, 95% CI: 0.2, 1.9), and had higher body mass index for age (MD = 0.6 SD, 95% CI: 0.2, 0.9).
169 riable linear regression was used to compare body mass index groups.
170 arison with in-person MESA examinations, and body mass index in HealthLNK in comparison with MESA, we
171                                     Elevated body mass index in midlife was associated with elevated
172 tic variants and age, sex, hypertension, and body mass index in the AFGen Consortium.
173 l suggestive interactions with age, sex, and body mass index in the discovery analysis.
174 r for increasing adiposity levels (leptin by body mass index interaction, p < .02), strengthening the
175                                              Body mass index is an imperfect measure of surgical risk
176 e range [IQR], 43.7-57.6 years) and a median body mass index of 27.8 kg/m(2) (IQR, 26.0-33.1 kg/m(2))
177         Patients had a mean age of 58 years, body mass index of 28 kg/m, 77% had contaminated wounds,
178                                              Body Mass Index of 30kg/m(2) or greater, prior combat de
179                                         Mean body mass index of all patients was 44 +/- 11 kg/m, mean
180 at this might in part be due to an increased body mass index or a reduced eosinophil count.
181 07) was a stronger predictor of increases in body mass index than were dysthymic disorder (B = -0.31
182 ariables, we suggest that an increase of one body mass index unit reduces lifespan by 7 months while
183                                     The mean body mass index was 25.5 +/- 5.2 in patients transplante
184 sults Mean (+/- standard deviation) age, and body mass index were 57.5 (+/- 10.1) years and 36.1 (+/-
185  cardiometabolic phenotypes above and beyond body mass index with subclinical measures of LV mechanic
186 mmol/L; 95% CI, -29.1 to -20.5; P < 0.0001), body mass index z score (+0.15; 95% CI, 0.08 to 0.22; P
187                                  Analysis of body mass index z score and fat mass in the same cohort
188    The primary outcome was 6-month change in body mass index z score.
189                                    Offspring body mass index z scores (BMIZs) were calculated by usin
190 n A deficiencies, inflammation, malaria, and body mass index) and distal risk factors (e.g., educatio
191 and 10 men; mean age +/- SD, 23.3 +/- 3.8 y; body mass index, 23.7 +/- 2.5 kg/m(2)) underwent (11)C-m
192 ucasian; mean age, 55.4 +/- 20.1 years; mean body mass index, 27.9 +/- 5.5 kg/m(2); mean length of BE
193 ntervention study of 44 overweight or obese (body mass index, 28-40 kg/m(2)) prediabetic men and wome
194 Of 278 participants (age, 48 years, 89% men, body mass index, 30.8 kg/m(2)), 86% completed the trial
195  1,696 exams were attempted in 992 patients (body mass index, 33.6 +/- 6.5 kg/m(2) ) with histologica
196 pertension and moderately overweight status (body mass index, 39 kg/m(2)).
197 any individual causative risk factor such as body mass index, age, or smoking status.
198                           Age, hypertension, body mass index, and African-American race were independ
199            Median (interquartile range) age, body mass index, and body surface area were 68 (57-77) y
200 dditive models after adjusting for age, sex, body mass index, and estimated glomerular filtration rat
201 ase, cardiovascular disease, age>/=75 years, body mass index, and higher systolic BP.
202  risk factors such as hypertension, smoking, body mass index, and hypercholesterolemia.
203 ere frequency-matched for age, sex, baseline body mass index, and Kellgren-Lawrence score.
204 gender, duration and familial history of HS, body mass index, and location.
205 known associations between OSA and sex, age, body mass index, and medical comorbidities through multi
206 roups were well balanced in terms of weight, body mass index, and most potential confounders.
207 hemoglobin A1c, level of C-reactive protein, body mass index, and platelet count were used to develop
208 which controlled for fiber intake, sex, age, body mass index, and repeated sampling within each parti
209 o adjustment for age, sex, employment grade, body mass index, and smoking status.
210                            BP, serum lipids, body mass index, and smoking were assessed in all follow
211 position, chronic illnesses, sleep problems, body mass index, and smoking.
212  interval 1.07-7.90), adjusted for age, sex, body mass index, and statin use.
213 y lipoprotein cholesterol, triglycerides and body mass index, and subsequent meta-analysis with META-
214 enetics of general adiposity, as measured by body mass index, and that of abdominal obesity, as measu
215 associated with age, female sex, height, and body mass index, and these variables accounted for 28% o
216                    After adjustment for age, body mass index, aortic valve calcification density, and
217 e study and after the 6-week diet period for body mass index, body composition, hip circumference, re
218               Clinical parameters, including body mass index, CD4 cell count, HIV load, and C-reactiv
219  such as gender, race, ethnicity, education, body mass index, chronic obstructive pulmonary disease,
220 nd procedural data were collected, including body mass index, comorbidities, tumor histologic charact
221 ) and 95% CIs, with adjustments for maternal body mass index, delivery year, socioeconomic status, ag
222 ith adjustment for age, sex, race/ethnicity, body mass index, diabetes status, diagnosis year, and ca
223   There were no differences in baseline age, body mass index, diabetes, chronic obstructive pulmonary
224 , family history of cardiovascular diseases, body mass index, diabetes, smoking, sedentary behaviors,
225                         Waist circumference, body mass index, fasting plasma glucose, glycohemoglobin
226 rs of age) and cardiometabolic risk factors (body mass index, fat mass index, blood pressure, physica
227 ent variable identified age, smoking status, body mass index, haemoglobin, serum uric acid, serum alb
228 cording to their lifestyle factors including body mass index, healthy diet, sedentary lifestyle, alco
229 cluded operation type, NAS >/= 5, bilirubin, body mass index, hemoglobin A1C, and dyslipidemia.
230   Achievement of ideal blood pressure, ideal body mass index, ideal glucose control, and nonsmoking w
231 s were observed between anorexia nervosa and body mass index, insulin, glucose, and lipid phenotypes.
232 atient characteristics (age, weight, height, body mass index, Karnofsky score), were merged to charac
233           Patients were well matched by age, body mass index, major comorbidities, and cardiac functi
234 y significant genetic interactions with sex, body mass index, or hypertension on AF risk.
235 d according to age and race and adjusted for body mass index, parity, and menopausal status, and the
236                      Adjusting for age, sex, body mass index, physical activity, and smoking in child
237 tus, educational level, alcohol consumption, body mass index, physical activity, body fat percentage,
238 HRs) with adjustments for baseline age, sex, body mass index, physical activity, symptoms, and radiog
239 s were performed by categorizing patients by body mass index, prealbumin, transferrin, phosphate, uri
240                     After adjusting for age, body mass index, race, current smoking status, and recen
241 io from a food frequency questionnaire, age, body mass index, race, supplement use, smoking status, e
242  (n = 10) subjects, matched for age, sex and body mass index, received either a 6 h lipid or glycerol
243 In a multiple variable model (including age, body mass index, sex, coronary artery calcium score, dia
244  lowest SBP stratum were older, had a higher body mass index, smoked more often, and had a higher fre
245 l environmental factors alcohol consumption, body mass index, smoking and maternal smoking during pre
246 ards models that were adjusted for age, sex, body mass index, smoking status, education, energy intak
247 al logistic regression analyses adjusted for body mass index, smoking, hypertension, diabetes, and sy
248 tion with a partner, height, early pregnancy body mass index, smoking, year of delivery, maternal pre
249 in models including adjustment for age, sex, body mass index, socioeconomic position, diet, smoking,
250     TMAO was positively associated with age, body mass index, type 2 diabetes mellitus and inversely
251 cholesterol, triglycerides, fasting glucose, body mass index, waist circumference, heart rate (HR) an
252                         After accounting for body mass index, we found that central adiposity, as mea
253                                      Gender, body mass index, weight, vascular access type, length, s
254 effects of sulfonylureas versus metformin on body mass index, where the variables baseline body mass
255                 Multivariable (age, sex, and body mass index-adjusted) linear regression models were
256  race or ethnicity, socioeconomic status, or body mass index.
257  destination therapy, and increased baseline body mass index.
258 sex, left ventricular ejection fraction, and body mass index.
259 for potentially relevant covariates, such as body mass index.
260 rs, such as smoking, alcohol consumption and body mass index.
261 lucose levels, diastolic blood pressure, and body mass index.
262 and utilization stratified by age, race, and body mass index.
263 FP edema, with adjustments for age, sex, and body mass index.
264 onocytes stratified by prepregnancy maternal body mass index.
265 how a decreased success rate with increasing body mass index.
266  levels of sputum eosinophils and had a high body mass index.
267       About 20% of the risk was observed for body mass index.
268 on equations did not capture dependencies on body mass index.
269  of severity of liver disease independent of body mass index.
270 bles assessed included: 1) periodontitis; 2) body mass index; 3) waist circumference to height (WHTR)
271                            Diabetes and high body-mass index (BMI) are associated with increased risk
272 l 1, 2006, to March 31, 2011, in relation to body-mass index (BMI) at recruitment, overall and for ca
273                                        Lower body-mass index (BMI) z-score and household smoking were
274 tified the burden of disease related to high body-mass index (BMI), according to age, sex, cause, and
275 ts were associated with waist circumference, body-mass index (BMI), and body fat percentage.
276                  The secondary outcomes were body-mass index (BMI), mood, anxiety, affective regulati
277 pulation attributable fractions for smoking, body-mass index (BMI), physical activity, alcohol intake
278              Severe obesity was defined as a body-mass index (BMI, the weight in kilograms divided by
279 at its levels are negatively correlated with body-mass index and insulin sensitivity.
280  by CT density, COPD assessment test scores, Body-mass index, airflow Obstruction, Dyspnea, and Exerc
281 nd valve disease) and non-cardiac variables (body-mass index, chronic kidney disease, and chronic obs
282 lonely individuals and others in biological (body-mass index, systolic and diastolic blood pressure,
283 rollment had their body weights measured and body mass indices calculated at baseline and at year 3.
284 ght into the genetics of lean body mass.Lean body mass is a highly heritable trait and is associated
285 d RCT was powered on a 5% difference in lean body mass (LBM) at 1 month.
286 rovide new insight into the genetics of lean body mass.Lean body mass is a highly heritable trait and
287           In children, the handgrip strength/body mass levels for a low metabolic risk were 0.359 and
288 ght, dental eruption pattern, and associated body mass of 69 notoungulate taxa, placed in their phylo
289 iated with concurrent changes in the average body mass of individuals, sometimes referred to as the '
290  the causes and consequences of variation in body mass of wild female Svalbard reindeer (Rangifer tar
291 either kinship nor familiarity was linked to body mass or telomere loss in female territory owners.
292 l boundaries over six orders of magnitude of body mass regardless of food types.
293 r substantial progress by adapting strategic body mass regulation models from evolutionary ecology to
294                                        April body mass showed no long-term trend (coefficient of vari
295 disruption was associated with reduced adult body mass, social avoidance, and hyperactivity.
296  athletes had greater peak power relative to body mass than other rugby athletes (14%; P = 2 x 10(-6)
297 he intra-individual change in skull size and body mass throughout the full cycle in wild recaptured s
298 d the animal's biological traits such as the body mass, typical movement velocity and the typical dur
299 bjects from 25 cohorts for appendicular lean body mass was successful for five single-nucleotide poly
300 omen who later developed HF had higher total body mass when compared with those versus those who did

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top